Amgen posted strong earnings beat and has an attractive dividend, and technical chart forecasting positive future performance ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...

As BMI is increasingly recognized as an imperfect way to measure health, UVA researchers share other metrics they rely upon.

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

Novo Nordisk NVO is scheduled to report fourth-quarter 2024 results on Feb. 5, 2025, before the opening bell. The Zacks ...

According to Trace One, when factoring in eating habits, food insecurity rates, alcohol consumption, and the prevalence of ...

Viking Therapeutics VKTX is set to report fourth-quarter and full-year 2024 earnings on Feb. 5, after market close. Since the ...

Metsera, Inc. aims to raise $275 million in an IPO to fund its clinical-stage biopharma programs targeting obesity and ...

A report published last week in “The Lancet Diabetes & Endocrinology” strives to redefine obesity. An international group convened to examine the longstanding concept and are recommending better ...

If you are overweight or have obesity, a reduction of as little as ... Once a week, get on the scale. Then chart your weight (this is easy to do via an app, or you can DIY using a graph).

However, the Food and Drug Administration (FDA) has not approved berberine for treating any medical conditions in the United States, including obesity. Research into whether it could be a safe or ...